Showing results (151-160 of 398) with videos related to
Sort By:
Pageof 40
Journal of Cancer|March 10, 2016
The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETsSeung Tae Kim, Sang Yun Ha, Sujin Lee, et al.Cancer Research and Treatment|February 20, 2024
Neoadjuvant Cisplatin-Based Chemotherapy Followed by Selective Bladder Preservation Chemoradiotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder: Post Hoc Analysis of Two Prospective StudiesSung Wook Cho, Sung Hee Lim, Ghee Young Kwon, et al.JCO Precision Oncology|July 6, 2026
Genomic Landscape of GNAQ and GNA11 Mutations in Metastatic Solid Tumors: A Real-World Data AnalysisMinsuk Kwon, Yunjin Go, Ji Eun Shin, et al.Cancer Research and Treatment|January 24, 2013
Outcomes of third-line docetaxel-based chemotherapy in advanced gastric cancer who failed previous oxaliplatin-based and irinotecan-based chemotherapiesMin Jeong Lee, In Gyu Hwang, Joung-Soon Jang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2022
Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU)Jonathan E Rosenberg, Se Hoon Park, Vadim Kozlov, et al.Biomaterials|February 20, 2024
Patient-derived tumor spheroid-induced angiogenesis preclinical platform for exploring therapeutic vulnerabilities in cancerJihoon Ko, Sujin Hyung, You Jeong Heo, et al.Medical Oncology (Northwood, London, England)|December 1, 2010
Salvage S-1 monotherapy in metastatic colorectal cancer patients who failed irinotecan-based or oxaliplatin-based chemotherapyDuk Joo Lee, Jeeyun Lee, Ha Yeon Lee, et al.Clinical Genitourinary Cancer|September 2, 2019
Novel Predictive Models of Early Death Less Than 1 Year in Patients With Metastatic Renal Cell Carcinoma After Treatment With First-line Tyrosine Kinase InhibitorsSeung Jea Shin, Taejin Kim, Hyun Hwan Sung, et al.Urologic Oncology|November 4, 2008
Molecular biomarkers for advanced renal cell carcinoma: implications for prognosis and therapyHyo Song Kim, Won Seog Kim, Se Hoon Park, et al.Scientific Reports|December 24, 2014
Anti-tumor efficacy of fulvestrant in estrogen receptor positive gastric cancerJun Ho Yi, In-Gu Do, Jiryeon Jang, et al.Pageof 40